AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Telmitan-CT 6.25 Tablet

Prescription Icon
Prescription Required

Marketer

Accilex Diacardo

Salt Composition

Telmisartan (40mg) + Chlorthalidone (6.25mg)

Overview Telmitan-CT 6.25 Tablet

Combiflex-HP 6.25mg tablets combine two active ingredients to effectively manage hypertension. This dual action reduces the long-term risk of stroke and heart attack. Combiflex-HP 6.25mg can be taken with or without food, the dosage adjusted based on individual response and medical condition. Consistent daily timing is recommended. Continue taking this medication as directed by your physician; discontinuation increases stroke and heart attack risk. The formulation includes a diuretic, increasing urination; therefore, avoid taking it within four hours of bedtime. Regular use, even when feeling well, is crucial for optimal benefit as high blood pressure often presents without symptoms. Dizziness is the most common adverse reaction; others include nausea, diarrhea, headache, and altered lipid profiles. Increased urination is a desired therapeutic effect, not a side effect. While rare, other side effects are possible. Consult the accompanying patient information leaflet and inform your doctor of any persistent or bothersome side effects; dosage adjustments or alternative medications may be considered. This medication is contraindicated during pregnancy and should only be used under medical supervision if you have kidney or liver disease, heart conditions, or diabetes. Consuming alcohol concurrently may exacerbate blood pressure lowering and side effects.

Uses of Telmitan-CT 6.25 Tablet

Elevated blood pressure

Major Benefits of Telmitan-CT 6.25 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmitan-CT 6.25 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.

Common Side effects of Telmitan-CT 6.25 Tablet:

  • Dizziness
  • Back pain
  • Sinus infection
  • Diarrhea
  • Red spots or bumps
  • Decreased potassium level in blood
  • Increased uric acid level in blood
  • Postural hypertension (high blood pressure)
  • Impotence
  • Loss of appetite
  • Gastrointestinal disturbance

How to use Telmitan-CT 6.25 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmitan-CT 6.25 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.

How Telmitan-CT 6.25 Tablet works:

Each Telmitan-CT 6.25mg tablet contains a dual-drug formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Telmitan-CT 6.25 Tablet use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Telmitan-CT 6.25mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated except in rare, life-threatening circumstances where the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

The medication Telmitan-CT 6.25 Tablet is contraindicated for breastfeeding mothers due to the potential for infant harm from the drug's components.

DrivingDrivingUNSAFE

Taking Telmitan-CT 6.25 mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Telmitan-CT 6.25 mg tablets, as dose modification may be necessary. Physician consultation is advised; administration is generally discouraged in such cases.

LiverLiverCAUTION

Patients with liver impairment should use Telmitan-CT 6.25 mg tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Telmitan-CT 6.25 Tablet :

Should you forget a Telmitan-CT 6.25 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telmitan-CT 6.25 Tablet

LabelValue
Addictive None.
Medication Classification Heart-related

FAQs on Telmitan-CT 6.25 Tablet

Telmitan-CT 6.25 mg tablets contain a dual-action formulation to manage hypertension. This medication lowers blood pressure, thus mitigating the likelihood of stroke and myocardial infarction.
Telmitan-CT 6.25 Tablet may induce dizziness, including feelings of faintness, weakness, unsteadiness, or lightheadedness, in certain individuals. Experiencing these symptoms warrants a period of rest; activities should be resumed only after the dizziness subsides.
Patients with hypersensitivity to any Telmitan-CT 6.25 Tablet constituent should not take this medication. Individuals with significant hepatic or renal dysfunction, and those experiencing anuria, should refrain from using Telmitan-CT 6.25 Tablets. The medication is also contraindicated for women during the second and third trimesters of pregnancy.
Store this medication in its original, tightly sealed container or packaging. Follow the storage directions provided on the packaging or label. Discard any unused or outdated medication. Prevent access by children, pets, and others.
Maintaining Telmitan-CT 6.25 Tablet, even with effectively reduced blood pressure, is crucial. Discontinuing this medication may cause blood pressure to rebound. These medications manage, but don't cure, high blood pressure; lifelong use is likely necessary. Consistent blood pressure control significantly minimizes the risk of stroke or heart attack.
Discontinue Telmitan-CT 6.25 Tablet only after discussion with your physician. Ceasing treatment may elevate blood pressure, increasing the risk of cardiovascular events such as stroke or heart attack. Report any ongoing adverse reactions to your doctor.
Sustained use of Telmitan-CT 6.25mg tablets is typically considered safe. Optimal efficacy for many blood pressure medications relies on extended treatment. Seek medical advice if you have any uncertainties.
Telmitan-CT 6.25 Tablet treatment is typically lifelong. Discuss any concerns about this medication with your physician before discontinuing use; never cease treatment without medical consultation.
Untreated high blood pressure often presents without noticeable symptoms, meaning blood pressure changes won't necessarily make you feel unwell. Consequently, this medication might not produce a perceptible improvement in how you feel. However, this doesn't indicate the medication is ineffective; it continues to work silently, lowering your risk of severe health complications.
Certain antihypertensive medications, such as diuretics like hydrochlorothiazide, can potentially impair erectile function in men. Conversely, some other blood pressure drugs might enhance erectile function. Consult your physician if you experience any concerns or changes. Currently, there's no conclusive data indicating Telmitan-CT 6.25 Tablet affects male or female fertility.
Maintaining a healthy lifestyle significantly enhances the effectiveness of Telmitan-CT 6.25 Tablet. Lowering dietary salt intake and implementing stress management techniques, such as yoga, meditation, or engaging in hobbies, are crucial. Prioritizing sufficient nightly sleep helps regulate blood pressure and reduce stress. Eliminating smoking and alcohol consumption contributes to lower blood pressure and cardiovascular health. Regular exercise and a balanced diet rich in whole grains, fresh produce, and low-fat options are also essential. For personalized guidance to optimize Telmitan-CT 6.25 Tablet benefits and overall well-being, consult your physician.
Telmitan-CT 6.25 Tablet
62
MRP 75
17% off